06/05/2025
8:26 AM | Cellectar Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2025
6:02 AM | Cellectar Biosciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/13/2025
6:15 AM | Cellectar Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/01/2025
5:04 AM | Cellectar Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/28/2025
3:36 PM | Cellectar Biosciences (Filer)
| Form DEFA14A | |
04/28/2025
3:31 PM | Cellectar Biosciences (Filer)
| Form DEF 14A | |
04/28/2025
3:32 PM | Cellectar Biosciences (Filer)
| Form ARS | |
03/17/2025
3:30 PM | Cellectar Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/13/2025
6:15 AM | Cellectar Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/13/2025
5:50 AM | Cellectar Biosciences (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/12/2025
8:44 PM | Cellectar Biosciences (Issuer)
Longcor Jarrod (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for CLRB and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Cellectar Biosciences and its competitors with MarketBeat's FREE daily newsletter. |
02/13/2025
2:49 PM | Cellectar Biosciences (Subject)
LYTTON LAURENCE W (Filed by)
| Form SCHEDULE 13G/A | |
02/06/2025
11:15 PM | Cellectar Biosciences (Filer)
| Form EFFECT | |
02/03/2025
3:57 PM | Cellectar Biosciences (Subject)
Rosalind Advisors, Inc. (Filed by)
| Form SCHEDULE 13G/A | |
01/27/2025
9:07 AM | Cellectar Biosciences (Subject)
HIRSCHMAN ORIN (Filed by)
| Form SCHEDULE 13G/A | |
01/14/2025
5:01 AM | Cellectar Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/11/2024
8:05 AM | Cellectar Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/18/2024
6:15 AM | Cellectar Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/18/2024
5:46 AM | Cellectar Biosciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/14/2024
3:53 PM | Cellectar Biosciences (Subject)
Nantahala Capital Management, LLC (Filed by)
| Form SCHEDULE 13G/A | |
11/01/2024
4:15 PM | Cellectar Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/29/2024
4:03 PM | Cellectar Biosciences (Filer)
| Form 10-Q/A | |
10/29/2024
4:09 PM | Cellectar Biosciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/29/2024
3:56 PM | Cellectar Biosciences (Filer)
| Form 10-K/A | |
08/23/2024
4:15 PM | Cellectar Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2024
6:15 PM | Cellectar Biosciences (Subject)
Rosalind Advisors, Inc. (Filed by)
| Form SC 13G/A | |
08/13/2024
5:45 AM | Cellectar Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/23/2024
11:15 PM | Cellectar Biosciences (Filer)
| Form EFFECT | |
07/23/2024
5:45 AM | Cellectar Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/22/2024
5:45 AM | Cellectar Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/11/2024
4:37 PM | Cellectar Biosciences (Subject)
Rosalind Advisors, Inc. (Filed by)
| Form SC 13G/A | |
07/11/2024
4:15 PM | Cellectar Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Buy CLRB Stock Free CLRB Stock Alerts